Keystone Symposia

This meeting took place in 2015

Here are the related meetings in 2020:
Diabetes: Glucose Control and Beyond (J5)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Diabetes and Metabolic Dysfunction (J6)

Organizer(s) Jeffrey E. Pessin, Alan R. Saltiel and Deborah M. Muoio
January 27—February 1, 2015
Santa Fe Community Convention Center • Santa Fe, NM USA
Discounted Abstract Deadline: Oct 1, 2014
Abstract Deadline: Oct 28, 2014
Scholarship Deadline: Oct 1, 2014
Discounted Registration Deadline: Nov 25, 2014

Sponsored by Intercept Pharmaceuticals, Inc., the Journal of Molecular Cell Biology (JMCB), MedImmune, Novo Nordisk A/S and Pfizer Inc. Supported by an educational donation provided by Amgen.

Summary of Meeting:
Diabetes and obesity-related complications and associated metabolic disorders are major public health problems at the local, national and global levels. These metabolic defects underlie the basis for multiple debilitating diseases including heart disease, stroke, blindness, kidney disease, hypertension, neural degeneration, wound healing, amputations, periodontal disease and birth defects. This meeting will address several cutting-edge aspects of molecular, cellular, tissue and integrative system metabolism that account for the metabolic defects that occur in diabetes and obesity. Several of these themes overlap with the concurrent meeting on Mitochondria, Metabolism and Heart Failure and four concurrent sessions are planned addressing distinct and novel aspects of normal and dysregulation muscle (skeletal and cardiac) intracellular signaling, mitochondria function/dynamics, aging and energy balance. Leaders in each of these respective areas will not only address basic and integrative mechanisms in model systems, but several will address these issues in human pathology. The diabetes-specific sessions reflect several key aspects of metabolic dysregulation in which novel information is currently forthcoming, causing a paradigm shift compared to our previous understanding of these processes. These include new information about tissue cross-talk, the inter-relationship between the control of glucose production and fatty acid synthesis that underlies selective insulin resistance and the role of normal and dysregulated circadian rhythms on metabolic processes. These cutting-edge advances will provide a foundation for identifying future research directions.

View Meeting Program


Early Career Investigator Travel Award Recipients

Michelle T. Foster
Colorado State University, USA

National Institute of General Medical Sciences (NIGMS) Ancillary Training Program Scholarship Recipients

Diego Scerbo
Columbia University, USA

Phillip Justin Webster
University of New Mexico, USA

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Scholarship Recipients

Alexander Bartelt
Ludwig-Maximilians-University, Germany

Prameladevi Chinnasamy
Einstein College of Medicine, Montefiore Medical Center, USA

Jorge Correia
Karolinska Institutet, Sweden

Frankie D. Heyward
University of Alabama at Birmingham, USA

Alison Iroz
Institut Cochin, France

Sharon Amadi Owino
Emory University, USA

Allyson Kaitlin Palmer
Mayo Clinic, USA

Mackenzie Jo Pearson
University of Texas Southwestern Medical Center, USA

Shannon M. Reilly
University of Michigan, USA

Evan Taddeo
University of California, Los Angeles, USA

Paul M. Titchenell
University of Pennsylvania, USA

Chad M. Trent
New York University Medical Center, USA

Risheng Ye
University of Texas Southwestern Medical Center, USA